Comparison of Resting Heart and Respiratory Rate Measurements Acquired by Contactless Radar Sensors, Electrocardiography, and Capnography
Status unconfirmed
Conditions studied: Vital Signs
In brief
1. Determine agreement (accuracy) of resting heart rate measured by Vitalpercept when compared to an FDA-cleared electrocardiograph (ECG) device, LifeSignals Wireless Biosensor. 2. Determine agreement (accuracy) of resting respiratory rate measured by Vitalpercept when compared to an FDA-cleared capnographer, Capnostream 20.
Key facts
- Study ID
- NCT04935190
- Run by
- DawnLight
- People needed
- 100
- Starts
- 2021-06-15
- Expected to finish
- 2021-10-30
- Last updated by the study team
- 2021-08-31
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Male or female subjects ≥ 21 years of age at the time of signing the informed consent.
- Subjects willing to sign the informed consent and capable of committing to the duration of the study.
- Subjects with the ability to lie flat, lie on left side, lie on right side, and sit in a chair.
- Subjects who are able to breathe through their nose for the capnography assessment.
- Subjects that have a diagnosis of a cardiac, pulmonary, or cardio-pulmonary condition (e.g., Congestive Heart Failure, COPD, Asthma) will be assigned to Group 1.
- Subjects who are not known to have a cardiac, pulmonary, or cardio-pulmonary condition will be assigned to Group 2.
You may not qualify if…
- Subjects who are prone to excessive coughing and excessive movement
- Subjects who have a condition that involves uncontrollable movement of the body such as Parkinson's Disease or Essential Tremor.
- Subjects with a history of allergy to adhesive, latex or Nuprep.
Where it is running
- North Carolina Clinical Research — Raleigh, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.